The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
It’s goodbye needles as you can keep the flu away with a nasal spray as the US Food and Drug Administration (FDA) has approved AstraZeneca’s FluMist for home use. It can be self-administered by adults ...
The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...
US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science- ...
In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.
The FDA approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
The US Food and Drug Administration has approved first self- or caregiver-administered flu vaccine FluMist.FluMist is ...